Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation

BACKGROUND: Direct oral anticoagulants (DOACs) are effective in reducing the stroke risk for patients with nonvalvular atrial fibrillation if prescribed at the labeled dose, yet underdosing is frequent. Little is known about clinician knowledge and patient or clinician preferences for DOAC dosing. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Rymer, Jennifer A., Webb, Laura, McCall, Debbe, Hills, Mellanie T., Wang, Tracy Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483523/
https://www.ncbi.nlm.nih.gov/pubmed/33998252
http://dx.doi.org/10.1161/JAHA.120.020697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483523/
https://www.ncbi.nlm.nih.gov/pubmed/33998252
http://dx.doi.org/10.1161/JAHA.120.020697

Ejemplares similares